Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

PubWeight™: 5.19‹?› | Rank: Top 1%

🔗 View Article (PMID 16874296)

Published in MMWR Recomm Rep on July 28, 2006

Authors

Advisory Committee on Immunization Practices1, Nicole M Smith, Joseph S Bresee, David K Shay, Timothy M Uyeki, Nancy J Cox, Raymond A Strikas

Author Affiliations

1: Influenza Division, National Center for Immunization and Respiratory Diseases, Atlanta, GA 30333, USA.

Associated clinical trials:

A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy | NCT00873886

Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant (H-100-001) | NCT00662272

Articles citing this

(truncated to the top 100)

The pathology of influenza virus infections. Annu Rev Pathol (2008) 5.37

Social contacts of school children and the transmission of respiratory-spread pathogens. Epidemiol Infect (2007) 3.59

Original antigenic sin responses to influenza viruses. J Immunol (2009) 2.76

Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci U S A (2007) 2.72

Influenza vaccination: policy versus evidence. BMJ (2006) 2.65

SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infect Control Hosp Epidemiol (2008) 2.35

The burden of influenza in young children, 2004-2009. Pediatrics (2013) 1.68

Evaluation of influenza prevention in the workplace using a personally controlled health record: randomized controlled trial. J Med Internet Res (2008) 1.68

Comparison of the MChip to viral culture, reverse transcription-PCR, and the QuickVue influenza A+B test for rapid diagnosis of influenza. J Clin Microbiol (2007) 1.63

Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus. PLoS One (2010) 1.61

New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets. PLoS One (2010) 1.59

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine (2007) 1.58

SHEA/APIC Guideline: Infection prevention and control in the long-term care facility. Am J Infect Control (2008) 1.56

Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics (2008) 1.56

Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus. Vaccine (2008) 1.54

Neighborhood socioeconomic status and influenza hospitalizations among children: New Haven County, Connecticut, 2003-2010. Am J Public Health (2011) 1.52

Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals. Influenza Other Respir Viruses (2008) 1.46

Automated Screening of Hospitalized Children for Influenza Vaccination. J Pediatric Infect Dis Soc (2013) 1.46

Evaluation of a multiplexed PCR assay for detection of respiratory viral pathogens in a public health laboratory setting. J Clin Microbiol (2007) 1.45

Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis (2014) 1.44

Tdap vaccination during pregnancy to reduce pertussis infection in young infants. Can Fam Physician (2013) 1.40

Identification of the N-terminal domain of the influenza virus PA responsible for the suppression of host protein synthesis. J Virol (2013) 1.32

Estimating the undetected burden of influenza hospitalizations in children. Epidemiol Infect (2006) 1.29

Influenza in older adults: impact of vaccination of school children. Vaccine (2009) 1.27

Immunogenetics of seasonal influenza vaccine response. Vaccine (2008) 1.25

Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. OMICS (2011) 1.21

A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults. Vaccine (2007) 1.20

Project VIVA: a multilevel community-based intervention to increase influenza vaccination rates among hard-to-reach populations in New York City. Am J Public Health (2008) 1.18

Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse. Virol J (2007) 1.15

Strategies for improving influenza immunization rates among hard-to-reach populations. J Urban Health (2007) 1.14

Prioritizing healthcare worker vaccinations on the basis of social network analysis. Infect Control Hosp Epidemiol (2010) 1.11

Influenza A and B infection in children in urban slum, Bangladesh. Emerg Infect Dis (2007) 1.11

Oseltamivir prescribing in pharmacy-benefits database, United States, 2004-2005. Emerg Infect Dis (2008) 1.10

Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults. PLoS One (2011) 1.09

Effect of rapid influenza testing on the clinical management of paediatric influenza. Influenza Other Respir Viruses (2009) 1.09

Predictive factors associated with the acceptance of pandemic and seasonal influenza vaccination in health care workers and students in Tuscany, Central Italy. Hum Vaccin Immunother (2013) 1.08

Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005. Medscape J Med (2008) 1.08

Impact of a school-based influenza immunization program on disease burden: comparison of two Tennessee counties. Vaccine (2009) 1.07

Inflammatory mechanisms of stroke. Stroke (2010) 1.06

Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol (2009) 1.04

Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults. Clin Vaccine Immunol (2007) 1.03

Impact of a web-based personally controlled health management system on influenza vaccination and health services utilization rates: a randomized controlled trial. J Am Med Inform Assoc (2012) 1.00

Viral tropism and the pathogenesis of influenza in the Mammalian host. Am J Pathol (2007) 1.00

Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998-2004. Vaccine (2007) 0.99

Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis (2008) 0.97

Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis (2007) 0.97

Practice and child characteristics associated with influenza vaccine uptake in young children. Pediatrics (2010) 0.96

Predictive validation of an influenza spread model. PLoS One (2013) 0.96

Antiviral strategies for pandemic and seasonal influenza. Viruses (2010) 0.95

Clinical review: primary influenza viral pneumonia. Crit Care (2009) 0.95

Influenza-associated morbidity in children with cancer. Pediatr Blood Cancer (2008) 0.94

A novel synthetic receptor-based immunoassay for influenza vaccine quantification. PLoS One (2013) 0.94

Thimerosal exposure and the role of sulfation chemistry and thiol availability in autism. Int J Environ Res Public Health (2013) 0.93

Human metapneumovirus infection among children, Bangladesh. Emerg Infect Dis (2007) 0.92

Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children. Influenza Other Respir Viruses (2009) 0.92

A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses. PLoS One (2012) 0.91

Trends in antibiotic use in Massachusetts children, 2000-2009. Pediatrics (2012) 0.91

Influenza-associated hospitalization in urban Thai children. Influenza Other Respir Viruses (2009) 0.89

Seroprevalence of influenza A and B in German infants and adolescents. Med Microbiol Immunol (2009) 0.88

Timeliness of pediatric influenza vaccination compared with seasonal influenza activity in an urban community, 2004-2008. Am J Public Health (2013) 0.88

A novel method to incorporate bioactive cytokines as adjuvants on the surface of virus particles. J Interferon Cytokine Res (2009) 0.87

Influenza and pneumococcal vaccination rates among Vietnamese, Asian, and non-Hispanic white Americans. J Immigr Minor Health (2008) 0.86

Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination. J Infect Dis (2015) 0.86

Influenza, immune system, and pregnancy. Reprod Sci (2014) 0.86

Protocol for a randomised controlled trial examining the impact of a web-based personally controlled health management system on the uptake of influenza vaccination rates. BMC Health Serv Res (2012) 0.85

Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases. J Clin Immunol (2007) 0.85

Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada. CMAJ (2011) 0.84

B cell responses to the 2011/12-influenza vaccine in the aged. Aging (Albany NY) (2013) 0.84

The epidemiology of hospitalized influenza in children, a two year population-based study in the People's Republic of China. BMC Health Serv Res (2010) 0.83

Multicomponent interventions to enhance influenza vaccine delivery to adolescents. Pediatrics (2011) 0.82

Trends in childhood influenza vaccination coverage--U.S., 2004-2012. Public Health Rep (2014) 0.82

Trends in pneumonia and influenza-associated hospitalizations in South Korea, 2002-2005. J Health Popul Nutr (2011) 0.81

A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults. Can J Infect Dis Med Microbiol (2008) 0.81

The evolutionary dynamics of receptor binding avidity in influenza A: a mathematical model for a new antigenic drift hypothesis. Philos Trans R Soc Lond B Biol Sci (2013) 0.81

Influence of sources of information about influenza vaccine on parental attitudes and adolescent vaccine receipt. Hum Vaccin Immunother (2015) 0.81

Prospective surveillance study of acute respiratory infections, influenza-like illness and seasonal influenza vaccine in a cohort of juvenile idiopathic arthritis patients. Pediatr Rheumatol Online J (2013) 0.80

Influenza immunization during pregnancy: Benefits for mother and infant. Hum Vaccin Immunother (2016) 0.80

A statewide system for improving influenza vaccination rates in hospital employees. Infect Control Hosp Epidemiol (2009) 0.80

Prevention and control of influenza in persons with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 0.80

Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons. Vaccine (2015) 0.79

Influenza vaccination coverage: findings from immunization information systems. BMC Pediatr (2007) 0.79

No evidence of avian influenza A (H5N1) among returning US travelers. Emerg Infect Dis (2007) 0.79

Tailored vaccines targeting the elderly using whole inactivated influenza vaccines bearing cytokine immunomodulators. J Interferon Cytokine Res (2013) 0.79

Infection prevention in the cancer center. Clin Infect Dis (2013) 0.79

Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011. Pediatrics (2014) 0.79

Effect of accessibility of influenza vaccination on the rate of childcare staff vaccination. Infect Control Hosp Epidemiol (2008) 0.78

Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease? Am J Geriatr Pharmacother (2010) 0.78

Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks. Crit Care (2010) 0.78

Predictors of influenza vaccination in the Cystic Fibrosis Foundation patient registry, 2006 through 2007. Chest (2010) 0.78

Genetic strategy to prevent influenza virus infections in animals. J Infect Dis (2008) 0.78

Monoclonal antibody specific to HA2 glycopeptide protects mice from H3N2 influenza virus infection. Vet Res (2015) 0.78

The influence of oseltamivir treatment on the risk of stroke after influenza infection. Cardiology (2008) 0.78

Immunization status of adult chiropractic patients in analyses of national health interview survey. J Manipulative Physiol Ther (2011) 0.77

A survey of pediatricians' attitudes regarding influenza immunization in children. BMC Pediatr (2009) 0.77

Influenza vaccine supply, 2005-2006: did we come up short? BMC Health Serv Res (2007) 0.77

Child, household, and caregiver characteristics associated with hospitalization for influenza among children 6-59 months of age: an emerging infections program study. Pediatr Infect Dis J (2014) 0.77

Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus. J Virol (2015) 0.76

Protecting pediatric oncology patients from influenza. Oncologist (2013) 0.76

Humoral and cellular immune responses to influenza vaccination in children with cancer receiving chemotherapy. Oncol Lett (2012) 0.76

Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes. BMJ Open Diabetes Res Care (2015) 0.76

Articles by these authors

Finding the missing heritability of complex diseases. Nature (2009) 67.95

Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75

Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61

Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23

Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (2005) 17.19

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med (2009) 16.13

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med (2009) 15.02

Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med (2005) 14.59

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13

Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet (2010) 10.75

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59

Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med (2008) 10.27

The allelic architecture of human disease genes: common disease-common variant...or not? Hum Mol Genet (2002) 10.08

The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med (2010) 9.90

Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis (2003) 9.44

Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med (2009) 9.06

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep (2008) 9.02

Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science (2009) 8.61

A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science (2007) 8.38

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA (2006) 8.06

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis (2012) 8.02

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol (2005) 7.88

Rotavirus and severe childhood diarrhea. Emerg Infect Dis (2006) 7.80

Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med (2013) 7.52

Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2009) 6.52

Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci U S A (2006) 6.35

A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27

Transmission of equine influenza virus to dogs. Science (2005) 6.11

SCAN: SNP and copy number annotation. Bioinformatics (2009) 5.96

Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med (2015) 5.92

Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J Infect Dis (2002) 5.92

Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA (2005) 5.84

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA (2009) 5.84

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 5.80

Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med (2014) 5.74

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet (2005) 5.70

Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med (2009) 5.68

Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med (2003) 5.60

Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2011) 5.48

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis (2007) 5.21

Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med (2006) 5.14

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2004) 5.00

Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet (2011) 4.93

Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J Infect Dis (2002) 4.88

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci U S A (2007) 4.35

Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet (2011) 4.26

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17

Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16

Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet (2005) 4.15

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet (2008) 4.01

Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med (2013) 3.88

Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A (2007) 3.77

Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis (2006) 3.66

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2005) 3.50

Influenza vaccine effectiveness in the community and the household. Clin Infect Dis (2013) 3.40

Genetic architecture of transcript-level variation in humans. Am J Hum Genet (2008) 3.36

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis (2012) 3.35

Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol (2007) 3.33

Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep (2003) 3.32

2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol (2010) 3.32

Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis (2010) 3.29

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2002) 3.27

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis (2009) 3.26

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet (2013) 3.21

Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin Infect Dis (2012) 3.19

In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology (2011) 3.19

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med (2012) 3.05

Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus--Cambodia, 2006. J Infect Dis (2009) 3.05

Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis (2010) 3.02

Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis (2013) 3.00

Low frequency of poultry-to-human H5NI virus transmission, southern Cambodia, 2005. Emerg Infect Dis (2006) 2.98

Rotavirus vaccines: current prospects and future challenges. Lancet (2006) 2.97

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2003) 2.96